Gram-Positive Blood Culture (BC-GP) Utility Tray - The Verigene® Gram-Positive Blood Culture Nucleic - NANOSPHERE, INC.

Duns Number:164757242

Device Description: The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed using the sa The Verigene® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed using the sample-to-result Verigene® System is a qualitative, multiplexed in vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive bacteria which may cause bloodstream infection (BSI).

Want to know more about this Product? Request more information now!


More Product Details

Catalog Number

-

Brand Name

Gram-Positive Blood Culture (BC-GP) Utility Tray

Version/Model Number

20-011-018

Device Commercial Distribution Status

Not in Commercial Distribution

Commercial Distribution End Date

December 05, 2019

Issuing Agency

In GS1

Product Characteristics

MRI safety Status

Labeling does not contain MRI Safety Information

Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437)

-

Device labeled as "Not made with natural rubber latex"

-

For Single-Use

Yes

Prescription Use (Rx)

Yes

Over the Counter (OTC)

-

Kit

-

Combination Product

-

Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P)

-

FDA Premarket Submission

DEN120014,K122514

Product Code Details

Product Code

NQX

Product Code Name

System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen

Device Record Status

Public Device Record Key

b12cf139-4e88-4159-a061-5edcfa607c74

Public Version Date

December 21, 2020

Public Version Number

5

DI Record Publish Date

September 23, 2016

Additional Identifiers

Package DI Number

None

Quantity per Package

-

Contains DI Package

-

Package Discontinue Date

-

Package Status

-

Package Type

-

"NANOSPHERE, INC." Characteristics
Device Class Device Class Description No of Devices
2 A medical device with a moderate to high risk that requires special controls. 27